Correlation Between Protara Therapeutics and TRACON Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Protara Therapeutics and TRACON Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protara Therapeutics and TRACON Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protara Therapeutics and TRACON Pharmaceuticals, you can compare the effects of market volatilities on Protara Therapeutics and TRACON Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protara Therapeutics with a short position of TRACON Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protara Therapeutics and TRACON Pharmaceuticals.
Diversification Opportunities for Protara Therapeutics and TRACON Pharmaceuticals
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between Protara and TRACON is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Protara Therapeutics and TRACON Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TRACON Pharmaceuticals and Protara Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protara Therapeutics are associated (or correlated) with TRACON Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TRACON Pharmaceuticals has no effect on the direction of Protara Therapeutics i.e., Protara Therapeutics and TRACON Pharmaceuticals go up and down completely randomly.
Pair Corralation between Protara Therapeutics and TRACON Pharmaceuticals
Given the investment horizon of 90 days Protara Therapeutics is expected to generate 0.55 times more return on investment than TRACON Pharmaceuticals. However, Protara Therapeutics is 1.83 times less risky than TRACON Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. TRACON Pharmaceuticals is currently generating about -0.04 per unit of risk. If you would invest 335.00 in Protara Therapeutics on August 29, 2024 and sell it today you would lose (41.00) from holding Protara Therapeutics or give up 12.24% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 78.83% |
| Values | Daily Returns |
Protara Therapeutics vs. TRACON Pharmaceuticals
Performance |
| Timeline |
| Protara Therapeutics |
| TRACON Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Protara Therapeutics and TRACON Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Protara Therapeutics and TRACON Pharmaceuticals
The main advantage of trading using opposite Protara Therapeutics and TRACON Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protara Therapeutics position performs unexpectedly, TRACON Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TRACON Pharmaceuticals will offset losses from the drop in TRACON Pharmaceuticals' long position.| Protara Therapeutics vs. Vaccinex | Protara Therapeutics vs. Monopar Therapeutics | Protara Therapeutics vs. Surrozen | Protara Therapeutics vs. Ikena Oncology |
| TRACON Pharmaceuticals vs. Rezolute | TRACON Pharmaceuticals vs. XOMA Corp | TRACON Pharmaceuticals vs. Vincerx Pharma | TRACON Pharmaceuticals vs. Histogen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |